Van Leeuwen & Company, LLC Pfizer Inc Transaction History

Van Leeuwen & Company, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2024	BUY	$41.75 - $54.5 $4.11 Million - $5.36 Million	98,346 New	98,346 $5.04 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $38,952 - $50,848	-933 Reduced 0.94%	98,346 $5.04 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $2.16 Million - $2.64 Million	49,375 Added 98.94%	99,279 $4.34 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $2.32 Million - $2.75 Million	49,904 New	49,904 $2.62 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $1.41 Million - $1.83 Million	-43,468 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$36.98 - $41.52 $2,958 - $3,321	80 Added 0.18%	43,468 $1.88 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $1.3 Million - $1.42 Million	34,560 Added 391.48%	43,388 $1.84 Million
Q4 2018 Mar 13, 2019	BUY	$38.47 - $43.86 $12,502 - $14,254	325 Added 3.82%	8,828 $385,000
Q3 2018 Mar 13, 2019	BUY	$34.47 - $41.81 $293,098 - $355,510	8,503 New	8,503 $375,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Van Leeuwen & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Leeuwen & Company, LLC with notifications on news.